Skip to content

Sacrospinous ligament fixation or Elevate Posterior procedure in treatment of primary apical prolapse stage * 2: a matched cohort study.

Sacrospinous ligament fixation or Elevate Posterior procedure in treatment of primary apical prolapse stage * 2: a matched cohort study. - Elevate Posterior Cohort

Status
Unknown
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON39017
Enrollment
105
Registered
2013-07-15
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pelvic Organ prolapse

Interventions

Elevate Posterior or sacrospinous ligament fixation

Sponsors

Academisch Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Women with a primary apical compartment prolapse stage * 2 requiring surgery. Patients with co-existing posterior defects or concomitant perineal surgery (perineoplasty) can be included.

Exclusion criteria

Exclusion criteria: - Previous prolapse surgery - Women of reproductive age desiring future pregnancy and childbirth - Unwilling to return for follow-up or language barriers - Co-morbidity that is associated with increased surgical risks, for instance women with ASA 3 or 4 classification. Up to the physician to decide. - Poor cognitive function, as subjectively assessed by the physician. - History of or current major psychiatric illness as subjectively assessed by the physician.

Design outcomes

Primary

MeasureTime frame
Quality of life related to pelvic floor function after 12 months measured using validated disease-specific quality of life questionnaires (UDI, DDI, IIQ)

Secondary

MeasureTime frame
Sexual function at one year after intervention measured using the PISQ-12 questionnaire, POP-Q, morbidity (including post-operative pain, complications and recovery of normal daily activities), generic quality of life, repeated pelvic floor surgery within 12 months after intervention and cost analysis.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)